02 October 2026
17:30 -19:00 CEST
Chair: Prof. Per Ljungman
(Sweden)
17:30-17:35
Welcome, introduction, and opening remarks
Prof. Per Ljungman (Sweden)
17:35-17:50
The burden of CMV in HSCT, major milestones, and remaining challenges in CMV management
Prof. Per Ljungman (Sweden)
17:50-18:10
Optimization of CMV prophylaxis with letermovir in adult allogeneic HSCT recipients:
emerging real-world evidence
Prof. Genovefa Papanicolaou (USA)
18:10-18:30
Advancing CMV management in pediatric allogeneic HSCT
Prof. Krzysztof Kałwak (Poland)
18:30-18:50
Panel discussion and Q&A session
All faculty
18:50-18:55
Closing remarks
Prof. Per Ljungman (Sweden)
